Es gab 50 kürzliche Insider-Transaktionen für Achison Inc. (ACHN), darunter 30 Käufe und 20 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $17.71M und die gesamten Insider-Verkäufe auf $4.77M.
Bedeutende Insider mit kürzlicher Aktivität umfassen New Living Ventures Llc, Manning Martha E, Kishbauch Michael D. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ACHN
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-04-10 |
New Living Ventures Llc |
10 Percent Owner |
Veräußerung |
- |
- |
- |
29,215,000 |
| 2020-01-29 |
Manning Martha E |
General Counsel |
Aktienrückgabe |
135,000 |
$4.11 |
$554.85K |
- |
| 2020-01-28 |
Kishbauch Michael D |
Director |
Aktienrückgabe |
30,000 |
$7.54 |
$226.2K |
- |
| 2020-01-28 |
Vitullo Nicole |
Director |
Aktienrückgabe |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Fisherman Jason S |
Director |
Aktienrückgabe |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Van Nostrand Robert L |
Director |
Aktienrückgabe |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Manning Martha E |
General Counsel |
Aktienrückgabe |
2,500 |
$6.30 |
$15.75K |
- |
| 2020-01-28 |
Truitt Joseph |
Chief Executive Officer |
Aktienrückgabe |
1,097,000 |
$2.18 |
$2.39M |
- |
| 2020-01-28 |
Verwiel Frank |
Director |
Aktienrückgabe |
42,000 |
$2.18 |
$91.56K |
- |
| 2020-01-28 |
Zelenkofske Steven |
EVP, Chief Medical Officer |
Aktienrückgabe |
200,000 |
$2.18 |
$436K |
- |
| 2020-01-28 |
Firuta Paul E |
EVP, Chief Commercial Officer |
Aktienrückgabe |
200,000 |
$2.18 |
$436K |
- |
| 2019-12-18 |
Van Nostrand Robert L |
Director |
Optionsausübung (Verkauf) |
20,000 |
$3.28 |
$65.6K |
- |
| 2019-11-14 |
Fisherman Jason S |
Director |
Optionsausübung (Verkauf) |
20,000 |
$3.28 |
$65.6K |
- |
| 2019-10-16 |
Truitt Joseph |
Chief Executive Officer |
Optionsausübung (Verkauf) |
33,250 |
$3.28 |
$109.06K |
- |
| 2019-01-23 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Vitullo Nicole |
Director |
RSU-Zuteilung |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Fisherman Jason S |
Director |
RSU-Zuteilung |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Van Nostrand Robert L |
Director |
RSU-Zuteilung |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Manning Martha E |
General Counsel |
RSU-Zuteilung |
150,000 |
$2.18 |
$327K |
150,000 |
| 2019-01-23 |
Truitt Joseph |
Chief Executive Officer |
RSU-Zuteilung |
1,097,000 |
$2.18 |
$2.39M |
1,097,000 |
| 2019-01-23 |
Verwiel Frank |
Director |
RSU-Zuteilung |
42,000 |
$2.18 |
$91.56K |
42,000 |
| 2019-01-23 |
Zelenkofske Steven |
Chief Medical Officer |
RSU-Zuteilung |
200,000 |
$2.18 |
$436K |
200,000 |
| 2019-01-23 |
Firuta Paul E |
Chief Operating Officer |
RSU-Zuteilung |
200,000 |
$2.18 |
$436K |
200,000 |
| 2018-12-14 |
Van Nostrand Robert L |
Director |
Optionsausübung (Verkauf) |
20,000 |
$1.05 |
$21K |
- |
| 2018-09-11 |
Firuta Paul E |
Chief Operating Officer |
RSU-Zuteilung |
400,000 |
$3.32 |
$1.33M |
400,000 |
| 2018-09-10 |
Firuta Paul E |
Chief Operating Officer |
Veräußerung |
- |
- |
- |
- |
| 2018-08-20 |
Zelenkofske Steven |
Chief Medical Officer |
Veräußerung |
- |
- |
- |
- |
| 2018-08-20 |
Zelenkofske Steven |
Chief Medical Officer |
RSU-Zuteilung |
500,000 |
$2.49 |
$1.25M |
500,000 |
| 2018-06-06 |
Fisherman Jason S |
Director |
Optionsausübung (Verkauf) |
20,000 |
$1.05 |
$21K |
- |
| 2018-05-31 |
Vitullo Nicole |
Director |
Sonstige (Verkauf) |
25,000 |
- |
- |
- |
| 2018-05-01 |
Truitt Joseph |
Chief Executive Officer |
RSU-Zuteilung |
632,000 |
$3.78 |
$2.39M |
632,000 |
| 2018-02-09 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Vitullo Nicole |
Director |
RSU-Zuteilung |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Fisherman Jason S |
Director |
RSU-Zuteilung |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Van Nostrand Robert L |
Director |
RSU-Zuteilung |
30,000 |
$2.90 |
$87K |
30,000 |
| 2018-02-09 |
Manning Martha E |
General Counsel |
RSU-Zuteilung |
215,000 |
$2.90 |
$623.5K |
215,000 |
| 2018-02-09 |
Deshpande Milind |
Chief Executive Officer |
RSU-Zuteilung |
640,000 |
$2.90 |
$1.86M |
640,000 |
| 2018-02-09 |
Truitt Joseph |
Chief Commercial Officer |
RSU-Zuteilung |
419,000 |
$2.90 |
$1.22M |
419,000 |
| 2018-02-09 |
Verwiel Frank |
Director |
RSU-Zuteilung |
30,000 |
$2.90 |
$87K |
30,000 |
| 2017-08-10 |
Vitullo Nicole |
Director |
Optionsausübung (Verkauf) |
20,706 |
$3.11 |
$64.45K |
- |
| 2017-06-28 |
Fisherman Jason S |
Director |
Erbschaft (Kauf) |
1,500 |
- |
- |
1,500 |
| 2017-01-19 |
Kishbauch Michael D |
Director |
RSU-Zuteilung |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Vitullo Nicole |
Director |
RSU-Zuteilung |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Fisherman Jason S |
Director |
RSU-Zuteilung |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Van Nostrand Robert L |
Director |
RSU-Zuteilung |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-19 |
Verwiel Frank |
Director |
RSU-Zuteilung |
30,000 |
$4.09 |
$122.7K |
30,000 |
| 2017-01-17 |
Manning Martha E |
EVP, General Counsel |
RSU-Zuteilung |
135,000 |
$4.11 |
$554.85K |
135,000 |
| 2017-01-17 |
Deshpande Milind |
Chief Executive Officer |
RSU-Zuteilung |
458,000 |
$4.11 |
$1.88M |
458,000 |
| 2017-01-17 |
Truitt Joseph |
Chief Commercial Officer |
RSU-Zuteilung |
185,000 |
$4.11 |
$760.35K |
185,000 |
| 2017-01-17 |
Apelian David |
Chief Medical Officer |
RSU-Zuteilung |
185,000 |
$4.11 |
$760.35K |
185,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
